Finally, biomarker-based screening pathway (combining assessment of endogenous insulin secretion with measurement of GADA and IA2A) increased the discriminatory ability and facilitated identification of even atypical cases and rarer forms of monogenic diabetes, which traditional criteria may miss (39) although as we have just pointed out the results obtained should be interpreted with caution. The gene discussed is INS; the disease is diabetes mellitus.